LINC02463

Across TCGA pan-cancer cohorts, LINC02463 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02463 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02463 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02463 expression acts as an unfavorable survival marker, although some lineages such as HNSC and READ show a favorable association.

LIHC, OV, and THCA are the cancer types where LINC02463 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.362	0.788	<.001	126	view →
OV	OS	Tertile	II,III,IV	0.201	0.336	.001	90	view →
THCA	OS	Tertile	IV	0.820	1.000	.001	87	view →
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	60	view →
HNSC	DFS	Quartile	All	0.731	0.494	.008	32	view →
LGG	DFS	Tertile	All	0.428	0.744	.001	27	view →
UCEC	OS	Tertile	III,IV	0.302	0.627	.015	24	view →
READ	OS	Median	IV	1.000	0.520	.011	16	view →
STAD	OS	Tertile	All	0.752	0.618	.020	14	view →
BRCA	DFS	Quartile	All	0.447	0.711	<.001	14	view →
KIRC	DFS	Tertile	All	0.309	0.648	<.001	12	view →
SARC	DFS	Tertile	All	0.422	0.623	.011	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02463–LIHC (OS)

Open the LIHC breakdown →